News
Mati Gil, CEO of AION Labs, describes how its new startup OMEC.AI came to fruition and what it aims to accomplish for drug discovery and development.
The company’s device, Primary Relief, is the latest of DyAnsys’ long list of devices to receive FDA clearance.
Device Connect for Fitbit aims to help healthcare and life science organizations use and analyze data from Fitbit's health-tracking wearables.
The company’s Seer Home device allows for potential epilepsy diagnosis through at-home data collection.
The JMIR study found themes like cost, functionality, progress tracking and educational content were important to consumers.
The technology uses heart rate variability measurements to assess the severity of sepsis in ED patients.
It will be used to test implants for hip and knee replacements.
A recent study found out-of-state telemedicine visits were most common with those who lived near a state border, and were largely for primary and mental healthcare.
Leslie Witt, Headspace Health's chief product and design officer, explains how the company's acquisitions are augmenting its mental health offerings and capabilities.
A recent study found patients using virtual reality while undergoing hand surgery required less anesthesia during surgery.